MNOV vs TDG · rev $645.4K vs P/E 41, rev $8.83B
MediciNova Inc (MNOV) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
MediciNova Inc (MNOV) is a biotechnology company listed on NASDAQ.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported MNOV revenue for 2026-06-30 was $645.4K. Net income was -$4.9M. MNOV currently screens at market cap $66.0M.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
MNOV currently screens at market cap $66.0M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the MNOV and TDG stock pages for the full models.
Not investment advice.